已关闭
  • 顶部Banner位
  • 固定模块
设置
BPD
试用
AI
企业管理端
厂家
FluA NP Antibody (5G11)
收藏 收藏
分享
原料试剂 研发实验室
价格
面议
品牌 近岸蛋白/Novoprotein
地区 -
货号 DA087
产地 国产
选择规格
1mg
500ug
50ug
易享客服
近岸蛋白
苏州近岸蛋白质科技股份有限公司
苏州
营业执照已审核
苏州近岸蛋白质科技股份有限公司(简称近岸蛋白,股票代码688137)深耕重组蛋白行业十余年,是一家专注于蛋白质技术与应用解决方案的高新技术企业,主营业务为生物药、体外诊断、mRNA疫苗药物、生命科学基础研究等领域的原料与技术解决方案,包括靶点及因子类蛋白、重组抗体、酶及试剂的研发、生产和销售及相关技术服务。公司在上海、苏州和菏泽建有研发、生产基地。
进入店铺
产品规格 图文详情 技术文档
产品规格
品牌名称
近岸蛋白/Novoprotein
货号
DA087
国产/进口
国产
规格
1mg,500ug,50ug
图文详情
The influenza A virus is the leading cause of annual influenza epidemics and occasional influenza pandemics. NP of influenza A virus plays a central role in viral replication. As a structural protein with no intrinsic enzymatic activity, it is the most abundant viral protein in infected cells. Monomeric NP is a 56 kDa protein with a patch of basic residues capable of binding to a single-strand RNA. NP also contains nuclear localization signals (NLS) and nuclear export signals (NES). The Influenza A virus nucleoprotein (NP) is the major protein component of the genomic viral ribonucleoprotein (vRNP) complexes, which are the replication- and transcription-competent units of Influenza viruses. Early during infection, NP mediates import of vRNPs into the host cell nucleus where viral replication and transcription take place; also newly synthesized NP molecules are targeted into the nucleus, enabling coreplicational assembly of progeny vRNPs.
技术文档
没有您想要的资料?去索要
返回顶部